Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet.

The role of the microbiome in liver disease

Open access
Schöler, David, Schnabl, Bernd·2024·Current Opinion in Gastroenterology

Abstract

Purpose of review: The intestinal microbiome and the gut-liver axis play a major role in health and disease. The human gut harbors trillions of microbes and a disruption of the gut homeostasis can contribute to liver disease. In this review, the progress in the field within the last 3 years is summarized, focusing on metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), autoimmune liver disease (AILD), and hepatocellular carcinoma (HCC). Recent findings: Changes in the fecal virome and fungal mycobiome have been described in patients with various liver diseases. Several microbial derived metabolites including endogenous ethanol produced by bacteria, have been mechanistically linked to liver disease such as MASLD. Virulence factors encoded by gut bacteria contribute to ALD, AILD and HCC. Novel therapeutic approaches focused on the microbiome including phages, pre- and postbiotics have been successfully used in preclinical models. Fecal microbiota transplantation has been effective in attenuating liver disease. Probiotics are safe in patients with alcohol-associated hepatitis and improve liver disease and alcohol addiction. Summary: The gut–liver axis plays a key role in the pathophysiology of liver diseases. Understanding the microbiota in liver disease can help to develop precise microbiota centered therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mog.0000000000001013

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 86 · Cited by 16

Metadata

Authors
Schöler, D., & Schnabl, B.
Affiliations
University of California San Diego (US)
Corresponding author
Schnabl, Bernd
Venue
Current Opinion in Gastroenterology
Published
2024-02-16
Volume
40
Issue
3
Pages
134-142
ISSN
  • 0267-1379 (ISSN-L)
  • 1531-7056
OpenAlex
W4391907080
Cited by
16
References
86
Citations by year
2026: 5 · 2025: 6 · 2024: 5
FWCI
0.65
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Current Opinion in Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by)
Funders
  • U.S. Department of Veterans Affairs (I01 BX004594)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA020703, U01AA026939, R01AA024726, P50AA011999, R37AA020703)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK120515)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
gut microbiota, gut-liver axis, liver disease, non-alcoholic fatty liver disease, alcoholic liver disease, autoimmune liver disease, hepatocellular carcinoma, fungal communities, virome, microbial metabolites, endogenous ethanol, bacterial virulence factors, phage therapy, prebiotics, postbiotics, fecal microbiota transplantation, probiotics, alcoholism, alcoholic hepatitis
MeSH terms
Gastrointestinal Microbiome, Hepatitis, Alcoholic, Carcinoma, Hepatocellular, Humans, Liver Diseases, Alcoholic, Liver Neoplasms, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of the microbiome in liver disease. https://app.cochat.ai/papers/10.1097/mog.0000000000001013
The paper
Schöler, D., & Schnabl, B. (2024). The role of the microbiome in liver disease. Current Opinion in Gastroenterology. https://doi.org/10.1097/mog.0000000000001013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.